CoChat

Evaluation of silver nanoparticles for the prevention of SARS-CoV-2 infection in health workers: In vitro and in vivo

Open access

Published version of a preprint

The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.

Abstract

SARS-CoV-2 infection in hospital areas is of a particular concern, since the close interaction between health care personnel and patients diagnosed with COVID-19, which allows virus to be easily spread between them and subsequently to their families and communities. Preventing SARS-CoV-2 infection among healthcare personnel is essential to reduce the frequency of infections and outbreaks during the pandemic considering that they work in high-risk areas. In this research, silver nanoparticles (AgNPs) were tested in vitro and shown to have an inhibitory effect on SARS-CoV-2 infection in cultured cells. Subsequently, we assess the effects of mouthwash and nose rinse with ARGOVIT ® silver nanoparticles (AgNPs), in the prevention of SARS-CoV-2 contagion in health workers consider as high-risk group of acquiring the infection in the General Tijuana Hospital, Mexico, a hospital for the exclusive recruitment of patients diagnosed with COVID-19. We present a prospective randomized study of 231 participants that was carried out for 9 weeks (during the declaration of a pandemic). The "experimental" group was instructed to do mouthwash and nose rinse with the AgNPs solution; the "control" group was instructed to do mouthwashes and nose rinse in a conventional way. The incidence of SARS-CoV-2 infection was significantly lower in the "experimental" group (two participants of 114, 1.8%) compared to the "control" group (thirty-three participants of 117, 28.2%), with an 84.8% efficiency. We conclude that the mouth and nasal rinse with AgNPs helps in the prevention of SARS-CoV-2 infection in health personnel who are exposed to patients diagnosed with COVID-19.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0256401

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig 1 Antiviral activity of AgNPs in Vero E6 cell cultures. A. Effect of AgNPs on viability of cultured Vero cells. Serial two-fold dilutions of AgNPs were added in triplicate to the medium of Vero cells seeded in 96-well plates. Viability at 24 (white bars), 48 (grey bars) and 72 h (black bars) was checked by the MTS Cell Proliferation Assay (Promega) and calculated as described in Methods. Statistically significant differences when compared to the corresponding 100% of cell viability (by 2 way ANOVA) are indicated. *, p < 0.05; ***, p < 0.001; ****, p < 0.0001. B. Percentages of infectivity values for each AgNPs concentration. The values were normalized to those in the absence of AgNPs (medium, 100%) and fitted using a non-linear regression algorithm. IC50: 50% inhibitory concentration. C. Representative SARS-CoV-2 plaque formation in presence of different dilutions of AgNPs.
Fig 1 Antiviral activity of AgNPs in Vero E6 cell cultures. A. Effect of AgNPs on viability of cultured Vero cells. Serial two-fold dilutions of AgNPs were added in triplicate to the medium of Vero cells seeded in 96-well plates. Viability at 24 (white bars), 48 (grey bars) and 72 h (black bars) was checked by the MTS Cell Proliferation Assay (Promega) and calculated as described in Methods. Statistically significant differences when compared to the corresponding 100% of cell viability (by 2 way ANOVA) are indicated. *, p < 0.05; ***, p < 0.001; ****, p < 0.0001. B. Percentages of infectivity values for each AgNPs concentration. The values were normalized to those in the absence of AgNPs (medium, 100%) and fitted using a non-linear regression algorithm. IC50: 50% inhibitory concentration. C. Representative SARS-CoV-2 plaque formation in presence of different dilutions of AgNPs.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 more claim about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 40 references

Cited by

See all 102

Metadata

Authors
Almanza-Reyes, H., Moreno, S., Plascencia-López, I., Alvarado-Vera, M., Patrón-Romero, L., Borrego, B., Reyes-Escamilla, A., Valencia-Manzo, D., Brun, A., Pestryakov, A., & Bogdanchikova, N.
Affiliations
  • Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria (ES)
  • Universidad Iberoamericana (MX)
  • Tomsk Polytechnic University (RU)
  • Universidad Nacional Autónoma de México (MX)
Corresponding author
  • Almanza-Reyes, Horacio
  • Moreno, Sandra
  • Alvarado-Vera, Martha
  • Borrego, Belén
  • Reyes-Escamilla, Alberto
  • Valencia-Manzo, Daniel
  • Brun, Alejandro
  • Pestryakov, Alexey
  • Bogdanchikova, Nina
Venue
PLOS ONE
Published
2021-08-19
Volume
16
Issue
8
Pages
e0256401
ISSN
1932-6203 (ISSN-L)
OpenAlex
W3193999063
Cited by
102
References
40
Citations by year
2026: 1 · 2025: 18 · 2024: 20 · 2023: 27 · 2022: 30 · 2021: 6
FWCI
6.30
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • medRxiv (acceptedVersion, cc-by-nd)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Tomsk Polytechnic University (Development Program "Priority 2030")
Topics
  • Physical Sciences › Materials Science › Materials Chemistry › Nanoparticles: synthesis and applications
  • Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Infection Control and Ventilation
Keywords
silver nanoparticles, SARS-CoV-2, COVID-19 prevention, healthcare workers, mouthwash, infection control, nosocomial infections, antiviral activity
MeSH terms
COVID-19, SARS-CoV-2, Adolescent, Adult, Aged, Animals, Chlorocebus aethiops, Female, Health Personnel, Humans, Male, Mexico, Middle Aged, Mouthwashes, Silver, Vero Cells, Metal Nanoparticles

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Evaluation of silver nanoparticles for the prevention of SARS-CoV-2 infection in health workers: In vitro and in vivo. https://app.cochat.ai/papers/10.1371/journal.pone.0256401
The paper
Almanza-Reyes, H., Moreno, S., Plascencia-López, I., Alvarado-Vera, M., Patrón-Romero, L., Borrego, B., Reyes-Escamilla, A., Valencia-Manzo, D., Brun, A., Pestryakov, A., & Bogdanchikova, N. (2021). Evaluation of silver nanoparticles for the prevention of SARS-CoV-2 infection in health workers: In vitro and in vivo. PLOS ONE. https://doi.org/10.1371/journal.pone.0256401

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.